TAB2 Antibodies

Santa Cruz Biotechnology offers a broad range of TAB2 monoclonal antibodies for research focused on understanding TAB2 protein functions. TAB2 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TAB2, or TGF-beta-activated kinase 1 (TAK1) binding protein 2, plays a crucial role in the regulation of cellular responses to stress and inflammation. TAB2 is involved in the activation of signaling pathways that mediate immune responses and cell survival, making it an important target for studies related to cancer, autoimmune diseases, and other inflammatory conditions. Understanding TAB2 function is essential for developing therapeutic strategies aimed at modulating these pathways. Research has shown that TAB2 interacts with multiple proteins in the NF-κB signaling cascade, contributing to inflammatory responses and cell survival mechanisms. TAB2 expression patterns vary across different tissue types and can be altered in various disease states. Recent studies have highlighted TAB2's potential as a therapeutic target in inflammatory diseases and cancer treatment. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance their understanding of TAB2's role in human health and disease.